Stockscreener 앱 받기
30.99
1.11%
0.34
시간 외 거래:
30.99
전일 마감가:
$30.65
열려 있는:
$30.67
하루 거래량:
1.14M
Relative Volume:
1.37
시가총액:
$2.92B
수익:
$4.72M
순이익/손실:
$-277.91M
주가수익비율:
-8.3083
EPS:
-3.73
순현금흐름:
$-203.56M
1주 성능:
+0.23%
1개월 성능:
+5.88%
6개월 성능:
-6.68%
1년 성능:
-41.20%
1일 변동 폭
$30.25
$31.22
1주일 범위
$29.91
$31.45
52주 변동 폭
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
명칭
Crinetics Pharmaceuticals Inc
전화
858-450-6464
주소
6055 LUSK BLVD., SAN DIEGO, CA
CRNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
30.99 | 2.89B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | Goldman | Neutral |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-11 | 개시 | TD Cowen | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Peer Perform |
| 2025-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-06 | 개시 | Citigroup | Buy |
| 2024-01-16 | 개시 | Morgan Stanley | Overweight |
| 2023-12-21 | 개시 | Jefferies | Hold |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-08-31 | 개시 | Oppenheimer | Outperform |
| 2023-04-24 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Robert W. Baird | Outperform |
| 2021-11-30 | 개시 | JMP Securities | Mkt Outperform |
| 2021-11-23 | 개시 | Evercore ISI | Outperform |
| 2021-06-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-23 | 개시 | ROTH Capital | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2018-08-13 | 개시 | JP Morgan | Neutral |
| 2018-08-13 | 개시 | Leerink Partners | Outperform |
| 2018-08-13 | 개시 | Piper Jaffray | Overweight |
모두보기
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Crinetics Pharmaceuticals Inc. stock retracement – recovery analysisEarnings Recap Report & Low Risk Entry Point Tips - Newser
How to build a custom watchlist for Crinetics Pharmaceuticals Inc.July 2025 Snapshot & Target Return Focused Picks - Newser
Published on: 2025-08-30 23:56:26 - Newser
What’s the recovery path for long term holders of Crinetics Pharmaceuticals Inc.Quarterly Trade Summary & AI Powered Market Entry Ideas - Newser
Can Crinetics Pharmaceuticals Inc. Outperform Peers After Recent Pullback getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-08-30 21:02:46 - Newser
Statistical indicators supporting Crinetics Pharmaceuticals Inc.’s strengthProfit Target & Intraday High Probability Setup Alerts - Newser
Is Crinetics Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Should you wait for a breakout in Crinetics Pharmaceuticals Inc.Share Buyback & Verified Trade Idea Suggestions - Newser
Crinetics Pharmaceuticals Inc. stock trend forecastFed Meeting & Reliable Price Breakout Signals - Newser
Will Crinetics Pharmaceuticals Inc. stock recover after recent drop2025 Price Targets & Low Risk Entry Point Tips - Newser
Crinetics Pharmaceuticals Inc. stock volume spike explainedRecession Risk & Weekly High Return Forecasts - Newser
Is Crinetics Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - Newser
How to forecast Crinetics Pharmaceuticals Inc. trends using time seriesJuly 2025 Price Swings & Expert Verified Movement Alerts - Newser
Understanding Crinetics Pharmaceuticals Inc.’s price movementEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
Published on: 2025-08-30 03:59:25 - Newser
Using Ichimoku Cloud for Crinetics Pharmaceuticals Inc. technicalsJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Heatmap analysis for Crinetics Pharmaceuticals Inc. and competitorsEarnings Risk Summary & Low Drawdown Trading Strategies - Newser
Analyzing Crinetics Pharmaceuticals Inc. with risk reward ratio chartsQuarterly Profit Review & Capital Efficiency Focused Strategies - Newser
Building trade automation scripts for Crinetics Pharmaceuticals Inc.Market Performance Report & Verified Short-Term Plans - Newser
How to interpret RSI for Crinetics Pharmaceuticals Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Crinetics Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Risk Analysis: Will Crinetics Pharmaceuticals Inc. stock go up in YEARTrade Exit Summary & Weekly High Conviction Trade Ideas - sundaytimes.kr
Volume spikes in Crinetics Pharmaceuticals Inc. stock – what they mean2025 Market Overview & Growth Focused Investment Plans - Newser
Combining price and volume data for Crinetics Pharmaceuticals Inc.2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Using data models to predict Crinetics Pharmaceuticals Inc. stock movementPortfolio Performance Summary & Safe Entry Trade Signal Reports - Newser
What high frequency data says about Crinetics Pharmaceuticals Inc.Market Movers & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-08-29 14:28:07 - Newser
What is the cash position of Crinetics Pharmaceuticals Inc.2025 Key Highlights & Free Daily Entry Point Trade Alerts - sundaytimes.kr
Crinetics Pharmaceuticals Inc (CRNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Crinetics Pharmaceuticals Inc 주식 (CRNX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Pizzuti Dana | Chief Med and Dev Officer |
Aug 22 '25 |
Sale |
30.43 |
30,000 |
912,900 |
66,270 |
0.96%
1.09%
자본화:
|
볼륨(24시간):